Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Daniel W. Cho
Washington +1 202 662 5451 dwcho@cov.com Download V-card

Daniel Cho is a litigator who represents a variety of clients in high-stakes patent litigation and intellectual property disputes. He has worked on matters at the Patent Trial and Appeal Board (PTAB), U.S. Court of Appeals for the Federal Circuit, and in U.S. district courts throughout the country.

Mr. Cho has experience representing clients in various stages of litigation, including case conception, trial, and appeal. He has represented clients in matters involving a broad array of technologies, including pharmaceuticals, medical devices, biotech, textiles, and gaming.

  • Representation of small pharmaceutical company in Hatch-Waxman litigation involving its sole product, a combination therapy used to maintain pupil size during cataract surgery or intraocular lens replacement and reduce postoperative pain.
  • Representation of Warner Chilcott in the Eastern District of Texas in patent litigation concerning Delzicol®, a drug used to treat a gastrointestinal disease.
  • Representation of Ventex Company as petitioner in two inter partes review (IPR) proceedings on heat management material.
  • Representation of Aristocrat Technologies in patent litigation and IPR proceedings against a competitor company in a case involving 32 patents concerning slot machine technology.
  • Representation of Biogen in defeating Swiss Pharma’s IPR attacks on three patents covering TYSABRI®, an antibody biologic for treating patients with multiple sclerosis.
  • Representation of AstraZeneca in a patent infringement dispute concerning the dose counters used with its SYMBICORT® inhaler product.

Previous Experience

  • Hon. John Z. Lee, United States District Court for the Northern District of Illinois, Judicial Extern (2015)
  • Republic of Korea Army, Sergeant (United Nations, ROK-US Combined Forces Command) (2010-2012)
  • United Nations Commission on International Trade Law (UNCITRAL), Legal Intern (2009)